Fish oil supplements show no heart benefit for diabetes
New research from the University of East Anglia finds omega-3 supplements don't improve cardiovascular outcomes in people with type 2 diabetes, challenging common health assumptions.
New research from the University of East Anglia finds omega-3 supplements don't improve cardiovascular outcomes in people with type 2 diabetes, challenging common health assumptions.
Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
Groundbreaking research reveals how your daily cuppa could be a powerful weapon against type 2 diabetes. Discover the science behind tea's protective benefits.
An NHS doctor highlights the subtle and often overlooked symptoms of type 2 diabetes, urging the public not to dismiss key changes in their body that could signal the condition.
Exclusive: British health authorities issue urgent alert about newly identified 'Type 5' diabetes, a deadly form striking young people with atypical symptoms and rapid progression.
New research from the UK finds eating whole apples, not just juice, significantly reduces the risk of developing type 2 diabetes. Discover the powerful benefits of this simple dietary change.
Groundbreaking NHS research reveals obesity injections like Wegovy are dramatically more effective than lifestyle changes alone for teenagers, offering new hope in the childhood obesity crisis.
Groundbreaking UK research reveals Hormone Replacement Therapy can significantly reduce the risk of developing type 2 diabetes in women, offering a potential new preventative treatment.
Exclusive investigation reveals the alarming trend of unregulated weight-loss jabs like Retatrutide being promoted on TikTok, posing severe health risks to UK users desperate for quick fixes.
A British mother who lost eight stone using 'fat jabs' has sparked a fierce debate by arguing the NHS should not fund them for weight loss, calling it a personal lifestyle choice rather than an essential right.
Celebrity chef Heston Blumenthal dramatically reduces portion sizes at his three-Michelin-starred restaurant, The Fat Duck, blaming the trend of appetite-suppressing weight-loss jabs. Diners report smaller dishes and a new 'snack' course as the culinary w
UK health officials issue urgent safety alert for popular slimming injections like Ozempic and Wegovy. Patients must disclose use before operations to prevent dangerous complications.
New research exposes a critical gap in the UK's health awareness, with Britons less likely to identify key diabetes symptoms compared to European neighbours. Experts warn this knowledge gap could lead to dangerous delays in diagnosis and treatment.
Exclusive: New NHS data reveals a shocking rise in diabetes diagnoses across Western countries, with the UK facing a growing healthcare emergency. Experts warn of unsustainable pressure on health services.
Shocking new report reveals the UK is falling behind other high-income countries in diagnosing diabetes, with nearly one million Brits living undiagnosed. Experts warn of a looming health catastrophe.
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
A UK mother's revelation that she uses her disability benefits to pay for weight-loss jabs like Wegovy has ignited a fierce national debate on welfare spending, medical ethics, and obesity treatment.
Shocking new data reveals a stark postcode lottery for the diabetes and weight loss drug Mounjaro (tirzepatide) in England, with patients in some areas almost completely unable to access it on the NHS despite being eligible.
Families across England face a devastating postcode lottery as NHS refuses to fund essential glucose monitors for children with Type 1 diabetes, forcing desperate parents to crowdfund for basic medical care.
New research from Harvard suggests that eating breakfast before 7am significantly reduces the risk of developing type 2 diabetes, challenging conventional wisdom on meal timing and metabolic health.
The NHS is dramatically expanding the availability of prescription weight-loss injections, hailed as a 'game-changer' in treating obesity. This major rollout could benefit hundreds of thousands more patients across England.
A UK mum shares her astonishing journey of losing four stone during pregnancy after a gestational diabetes diagnosis. Her story is a powerful testament to health transformation.
Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.
EXCLUSIVE: Tracey Cox exposes the hidden intimate costs of semaglutide injections. Discover why your marriage and sex life could be the ultimate price for rapid weight loss.
Exclusive: Strictly Come Dancing producers express serious concerns as celebrities reportedly turn to weight-loss injections ahead of the new series, fearing impacts on stamina and performance in the gruelling competition.
Groundbreaking research from the University of Sheffield suggests a daily cup of a common 3p hot drink could be a powerful weapon against type 2 diabetes, potentially reducing risk by a staggering amount.
Former Culture Minister Ed Vaizey calls for VAT removal on prescription obesity drugs, arguing it would boost public health and reduce long-term NHS costs.
Groundbreaking British research warns that popular weight-loss injections like Ozempic and Mounjaro may significantly increase hospitalisation risks for heart failure patients. Experts call for urgent review of prescription guidelines.
Ex-Culture Minister Ed Vaizey urges the NHS to widely prescribe revolutionary weight loss injections, calling them a potential 'miracle' for public health and a solution to the obesity crisis.
Groundbreaking UK research finds semaglutide-based drugs, popular for weight loss, significantly improve symptoms and physical limitations in obese heart failure patients, offering a new potential treatment avenue.